Trial
NCT02721979
Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
Janssen Scientific Affairs, LLC; National Cancer Institute (NCI)
Condition
Prostate Adenocarcinoma
Intervention
Apalutamide
Why stopped
Terminated due to slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-09